Literature DB >> 7822821

On the interaction between single chain Fv antibodies and bacterial immunoglobulin-binding proteins.

B Akerström1, B H Nilson, H R Hoogenboom, L Björck.   

Abstract

Using four bacterial immunoglobulin-binding proteins, we have analyzed the binding characteristics of a panel of 34 human single chain Fv antibodies, expressed in E. coli and with known specificity and sequence. Several of the single chain Fv antibodies showed affinity for staphylococcal protein A and peptostreptococcal protein L, but not for the streptococcal proteins G or H. The affinity of the binding was higher for protein L (4.5 and 1.4 x 10(9) M-1) than for protein A (7.7 and 6.7 x 10(8) M-1), using the two single chain Fv antibodies displaying the strongest binding activity to these ligands. The binding was shown to be specific by Western blotting, and the single chain Fv antibodies could be purified from crude bacterial culture media by affinity chromatography on protein L- or A-Sepharose. Protein A, which has affinity for the VH domain of the scFv antibodies, was tested against scFv antibodies containing VH1, VH3, VH4 and VH5 domains, and its binding was restricted to approximately half of the scFv antibodies with a VH3 domain. Protein L, which has affinity for the VL domain, was tested against kappa 1, kappa 4, lambda 1, lambda 2 and lambda 3 domains, and it bound all kappa 1 domains, one lambda 2 and one lambda 3 domain. Comparison of the amino acid sequences of binding and non-binding VL domains demonstrated that amino acid residues crucial to the binding of protein L were distributed over a large area outside the hypervariable antigen-binding regions.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7822821     DOI: 10.1016/0022-1759(94)90152-x

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  8 in total

1.  Identification and characterization of tumor antigens by using antibody phage display and intrabody strategies.

Authors:  Anne-Laure Goenaga; Yu Zhou; Christine Legay; Houcine Bougherara; Lan Huang; Bin Liu; Daryl C Drummond; Dmitri B Kirpotin; Christian Auclair; James D Marks; Marie-Alix Poul
Journal:  Mol Immunol       Date:  2007-05-10       Impact factor: 4.407

2.  Functional production and characterization of a fibrin-specific single-chain antibody fragment from Bacillus subtilis: effects of molecular chaperones and a wall-bound protease on antibody fragment production.

Authors:  Sau-Ching Wu; Jonathan C Yeung; Yanjun Duan; Ruiqiong Ye; Steven J Szarka; Hamid R Habibi; Sui-Lam Wong
Journal:  Appl Environ Microbiol       Date:  2002-07       Impact factor: 4.792

3.  Reverse calcium affinity purification of Fab with calcium derivatized hydroxyapatite.

Authors:  Pete Gagnon; Chia-Wei Cheung; Paul J Yazaki
Journal:  J Immunol Methods       Date:  2009-01-14       Impact factor: 2.303

4.  Degradation of C-terminal tag sequences on domain antibodies purified from E. coli supernatant.

Authors:  Simon Lykkemark; Ole Aalund Mandrup; Niels Anton Friis; Peter Kristensen
Journal:  MAbs       Date:  2014       Impact factor: 5.857

5.  Development of purification processes for fully human bispecific antibodies based upon modification of protein A binding avidity.

Authors:  Andrew D Tustian; Christine Endicott; Benjamin Adams; John Mattila; Hanne Bak
Journal:  MAbs       Date:  2016-03-10       Impact factor: 5.857

6.  Development of a novel affinity chromatography resin for platform purification of bispecific antibodies with modified protein a binding avidity.

Authors:  Andrew D Tustian; Linus Laurin; Henrik Ihre; Travis Tran; Robert Stairs; Hanne Bak
Journal:  Biotechnol Prog       Date:  2018-03-08

Review 7.  Superantigen Recognition and Interactions: Functions, Mechanisms and Applications.

Authors:  Anthony M Deacy; Samuel Ken-En Gan; Jeremy P Derrick
Journal:  Front Immunol       Date:  2021-09-20       Impact factor: 7.561

8.  Antibody light chain variable domains and their biophysically improved versions for human immunotherapy.

Authors:  Dae Young Kim; Rebecca To; Hiba Kandalaft; Wen Ding; Henk van Faassen; Yan Luo; Joseph D Schrag; Nadereh St-Amant; Mary Hefford; Tomoko Hirama; John F Kelly; Roger MacKenzie; Jamshid Tanha
Journal:  MAbs       Date:  2014 Jan-Feb       Impact factor: 5.857

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.